House Bill 467
117th Congress(2021-2022)
Protecting Patient Access to Lifesaving COVID–19 Drugs Act of 2021
Introduced
Introduced in House on Jan 25, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
467
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Protecting Patient Access to Lifesaving COVID-19 Drugs Act of 2021
This bill requires health insurance plans to cover COVID-19 (i.e., coronavirus disease 2019) antibody treatment at no cost for individuals who have tested positive for the virus.
January 25, 2021
02/02/2021
Referred to the Subcommittee on Health.
01/25/2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
01/25/2021
Referred to the Subcommittee on Health.
01/25/2021
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:43:29 PM